Zydus Lifesciences Limited (NSE: ZYDUSLIFE), ISIN INE010B01027 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ZYDUSLIFE last traded at ₹1122.40 (+2.07%), with a 52-week range of ₹835.85 to ₹1181.00 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 75.01%, FIIs 6.88%, DIIs 11.27%, mutual funds 5.12%.
EquiSense Score (ECS): 79/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.